Subchondral bone and osteoarthritis

Current Opinion in Rheumatology

Volumn 27, Issue 4, 2015, Pages 420-426

  Funck Brentano, Thomas ^a   Cohen Solal, Martine ^a  

^a INSERM   (France)

Author keywords

Bone; Bone mineral density; Bone remodeling; Cartilage; Osteoarthritis

Indexed keywords

BONE; BONE CELL; BONE DENSITY; BONE REMODELING; BONE TURNOVER; CARTILAGE CELL; CELL INTERACTION; DISEASE ASSOCIATION; DISEASE COURSE; EXPERIMENTAL STUDY; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SUBCHONDRAL BONE; TISSUE LEVEL; ARTICULAR CARTILAGE; BLOOD; CELL COMMUNICATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

BIOLOGICAL MARKER;

BIOMARKERS; BONE DENSITY; BONE REMODELING; CARTILAGE, ARTICULAR; CELL COMMUNICATION; CHONDROCYTES; HUMANS; MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS;

EID: 84942617004     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000181     Document Type: Review

References (69)

1. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494-502.
2. Findlay DM, Atkins GJ. Osteoblast-chondrocyte interactions in osteoarthritis. Curr Osteoporos Rep 2014;12:127-134.
3. Karsdal MA, Bay-Jensen AC, Lories RJ, et al. The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments? Ann Rheum Dis 2014;73:336-348.
4. Nevitt MC, Zhang Y, Javaid MK, et al. High systemic bone mineral density increases the risk of incident knee OA and joint space narrowing, but not radiographic progression of existing knee OA: the MOST study. Ann Rheum Dis 2010;69:163-168.
5. Hochberg MC. Do risk factors for incident hip osteoarthritis (OA) differ from those for progression of hip OA? J Rheumatol Suppl 2004;70:6-9.
6. Zhang Y, Hannan MT, Chaisson CE, et al. Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: the Framingham Study. J Rheumatol 2000;27:1032-1037.
7. Cao Y, Stannus OP, Aitken D, et al. Cross-sectional and longitudinal associations between systemic, subchondral bone mineral density and knee cartilage thickness in older adults with or without radiographic osteoarthritis. Ann Rheum Dis 2014;73:2003-2009.
8. Chaganti RK, Parimi N, Lang T, et al. Bone mineral density and prevalent osteoarthritis of the hip in older men for the Osteoporotic Fractures in Men (MrOS) Study Group. Osteoporos Int 2010;21:1307-1316.
9. Hardcastle SA, Gregson CL, Deere KC, et al. High bone mass is associated with an increased prevalence of joint replacement: a case-control study. Rheumatology 2013;52:1042-1051.
10. Hardcastle SA, Dieppe P, Gregson CL, et al. Osteophytes, enthesophytes, and high bone mass: a bone-forming triad with potential relevance in osteoarthritis. Arthritis Rheumatol 2014;66:2429-2439.
11. Castaño-Betancourt MC, Rivadeneira F, Bierma-Zeinstra S, et al. Bone parameters across different types of hip osteoarthritis and their relationship to osteoporotic fracture risk. Arthritis Rheum 2013;65:693-700.
12. Zeggini E, Panoutsopoulou K, Southam L, et al. Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet 2012;380:815-823.
13. Evangelou E, Chapman K, Meulenbelt I, et al. Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum 2009;60:1710-1721.
14. Baker-Le Pain JC, Lynch JA, Parimi N, et al. Variant alleles of the Wnt antagonist FRZB are determinants of hip shape and modify the relationship between hip shape and osteoarthritis. Arthritis Rheum 2012;64:1457-1465.
15. Yerges-Armstrong LM, Yau MS, Liu Y, et al. Association analysis of BMDassociated SNPs with knee osteoarthritis. J Bone Miner Res 2014;29:1373-1379.
16. Xu L, Hayashi D, Roemer FW, et al. Magnetic resonance imaging of subchondral bone marrow lesions in association with osteoarthritis. Semin Arthritis Rheum 2012;42:105-118.
17. Zanetti M, Bruder E, Romero J, et al. Bone marrow edema pattern in osteoarthritic knees: correlation between MR imaging and histologic findings. Radiology 2000;215:835-840.
18. Saadat E, Jobke B, Chu B, et al. Diagnostic performance of in vivo 3-T MRI for articular cartilage abnormalities in human osteoarthritic knees using histology as standard of reference. Eur Radiol 2008;18:2292-2302.
19. Taljanovic MS, Graham AR, Benjamin JB, et al. Bone marrow edema pattern in advanced hip osteoarthritis: quantitative assessment with magnetic resonance imaging and correlation with clinical examination, radiographic findings, and histopathology. Skeletal Radiol 2008;37:423-431.
20. Roemer FW, Guermazi A, Javaid MK, et al. Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis. Ann Rheum Dis 2009;68:1461-1465.
21. Driban JB, Tassinari A, Lo GH, et al. Bone marrow lesions are associated with altered trabecular morphometry. Osteoarthritis Cartilage 2012;20:1519-1526.
22. Crema MD, Roemer FW, Zhu Y, et al. Subchondral cystlike lesions develop longitudinally in areas of bone marrow edema-like lesions in patients with or at risk for knee osteoarthritis: detection with MR imaging: the MOST study. Radiology 2010;256:855-862.
23. Zhang Y, Nevitt M, Niu J, et al. Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging. Arthritis Rheum 2011;63:691-699.
24. Cotofana S, Wyman BT, Benichou O, et al. Relationship between knee pain and the presence, location, size and phenotype of femorotibial denuded areas of subchondral bone as visualized by MRI. Osteoarthritis Cartilage 2013;21:1214-1222.
25. Crema MD, Cibere J, Sayre EC, et al. The relationship between subchondral sclerosis detected with MRI and cartilage loss in a cohort of subjects with knee pain: the knee osteoarthritis progression (KOAP) study. Osteoarthritis Cartilage 2014;22:540-546.
26. Mapp PI, Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol 2012;8:390-398.
27. Binks DA, Gravallese EM, Bergin D, et al. Role of vascular channels as a novel mechanism for subchondral bone damage at cruciate ligament entheses in osteoarthritis and inflammatory arthritis. Ann Rheum Dis 2015;74:196-203.
28. Everhart JS, Siston RA, Flanigan DC. Tibiofemoral subchondral surface ratio (SSR) is a predictor of osteoarthritis symptoms and radiographic progression: data from the Osteoarthritis Initiative (OAI). Osteoarthritis Cartilage 2014;22:771-778.
29. Neogi T, Bowes MA, Niu J, et al. Magnetic resonance imaging-based three-dimensional bone shape of the knee predicts onset of knee osteoarthritis: data from the osteoarthritis initiative. Arthritis Rheum 2013;65:2048-2058.
30. Nelson AE, Liu F, Lynch JA, et al. Association of incident symptomatic hip osteoarthritis with differences in hip shape by active shape modeling: the johnston county osteoarthritis project. Arthritis Care Res 2014;66:74-81.
31. Kraus VB, Feng S, Wang S, et al. Subchondral bone trabecular integrity predicts and changes concurrently with radiographic and magnetic resonance imaging-determined knee osteoarthritis progression. Arthritis Rheum 2013;65:1812-1821.
32. Bettica P, Cline G, Hart DJ, et al. Evidence for increased bone resorption in patients with progressive knee osteoarthritis: Longitudinal results from the Chingford study. Arthritis Rheum 2002;46:3178-3184.
33. Dieppe P, Cushnaghan J, Young P, et al. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis 1993;52:557-563.
34. Huebner JL, Bay-Jensen AC, Huffman KM, et al. Alpha C-telopeptide of Type I collagen is associated with subchondral bone turnover and predicts progression of joint space narrowing and osteophytes in osteoarthritis. Arthritis Rheumatol 2014;66:2440-2449.
35. Li B, Aspden RM. Composition and mechanical properties of cancellous bone from the femoral head of patients with osteoporosis or osteoarthritis. J Bone Miner Res 1997;12:641-651.
36. Cox LGE, Van Donkelaar CC, Van Rietbergen B, et al. Decreased bone tissue mineralization can partly explain subchondral sclerosis observed in osteoarthritis. Bone 2012;50:1152-1161.
37. Ding M, Odgaard A, Hvid I. Changes in the three-dimensional microstructure of human tibial cancellous bone in early osteoarthritis. J Bone Jt Surg Br 2003;85:906-912.
38. Bobinac D, Spanjol J, Zoricic S, et al. Changes in articular cartilage and subchondral bone histomorphometry in osteoarthritic knee joints in humans. Bone 2003;32:284-290.
39. Chappard C, Peyrin F, Bonnassie A, et al. Subchondral bone micro-architectural alterations in osteoarthritis: a synchrotron micro-computed tomography study. Osteoarthritis Cartilage 2006;14:215-223.
40. Chiba K, Nango N, Kubota S, et al. Relationship between microstructure and degree of mineralization in subchondral bone of osteoarthritis: a synchrotron radiation mCT study. J Bone Miner Res 2012;27:1511-1517.
41. Bobinac D, Marinovic M, Bazdulj E, et al. Microstructural alterations of femoral head articular cartilage and subchondral bone in osteoarthritis and osteoporosis. Osteoarthritis Cartilage 2013;21:1724-1730.
42. Cohen-Solal M, Funck-Brentano T, Hay E. Animal models of osteoarthritis for the understanding of the bone contribution. BoneKEy Rep 2013;2.
43. Hayami T, Pickarski M, Zhuo Y, et al. Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 2006;38:234-243.
44. Funck-Brentano T, Lin H, Hay E, et al. Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism. PLoS ONE 2012;7:e33543.
45. Bellido M, Lugo L, Roman-Blas JA, et al. Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther 2010;12:R152.
46. Kadri A, Funck-Brentano T, Lin H, et al. Inhibition of bone resorption blunts osteoarthritis in mice with high bone remodelling. Ann Rheum Dis 2010;69:1533-1538.
47. Zhou X, Von Der Mark K, Henry S, et al. Chondrocytes transdifferentiate into osteoblasts in endochondral bone during development, postnatal growth and fracture healing in mice. PLoS Genet 2014;10:e1004820.
48. Priam S, Bougault C, Houard X, et al. Identification of soluble 14-3-32 as a novel subchondral bone mediator involved in cartilage degradation in osteoarthritis. Arthritis Rheum 2013;65:1831-1842.
49. Pan J, Wang B, Li W, et al. Elevated cross-talk between subchondral bone and cartilage in osteoarthritic joints. Bone 2012;51:212-217.
50. Chou C-H, Wu C-C, Song I-W, et al. Genome-wide expression profiles of subchondral bone in osteoarthritis. Arthritis Res Ther 2013;15:R190.
51. Lories RJ, Corr M, Lane NE. To Wnt or not to Wnt: the bone and joint health dilemma. Nat Rev Rheumatol 2013;9:328-339.
52. Funck-Brentano T, Bouaziz W, Marty C, et al. Dkk-1-mediated inhibition of Wnt signaling in bone ameliorates osteoarthritis in mice. Arthritis Rheumatol Hoboken NJ 2014;66:3028-3039.
53. Bouaziz W, Funck-Brentano T, Lin H, et al. Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent Wnt pathways. Arthritis Res Ther 2015;17:24.
54. Roudier M, Li X, Niu Q-T, et al. Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury. Arthritis Rheum 2013;65:721-731.
55. Chan TF, Couchourel D, Abed É, et al. Elevated Dickkopf-2 levels contribute to the abnormal phenotype of human osteoarthritic osteoblasts. J Bone Miner Res 2011;26:1399-1410.
56. Bouvard B, Abed E, Yéléhé-Okouma M, et al. Hypoxia and vitamin D differently contribute to leptin and dickkopf-related protein 2 production in human osteoarthritic subchondral bone osteoblasts. Arthritis Res Ther 2014;16:459.
57. Zhen G, Wen C, Jia X, et al. Inhibition of TGF-b signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 2013;19:704-712.
58. Lampropoulou-Adamidou K, Dontas I, Stathopoulos IP, et al. Chondroprotective effect of high-dose zoledronic acid: an experimental study in a rabbit model of osteoarthritis. J Orthop Res 2014;32:1646-1651.
59. Hayami T, Pickarski M, Wesolowski GA, et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 2004;50:1193-1206.
60. Hayami T, Zhuo Y, Wesolowski GA, et al. Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis. Bone 2012;50:1250-1259.
61. Sagar DR, Ashraf S, Xu L, et al. Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. Ann Rheum Dis 2014;73:1558-1565.
62. Pelletier J-P, Kapoor M, Fahmi H, et al. Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1b in the synovium. Ann Rheum Dis 2013;72:250-257.
63. Davis AJ, Smith TO, Hing CB, et al. Are bisphosphonates effective in the treatment of osteoarthritis pain? a meta-analysis and systematic review. PLoS ONE 2013;8:e72714.
64. Laslett LL, Doré DA, Quinn SJ, et al. Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial. Ann Rheum Dis 2012;71:1322-1328.
65. Laslett LL, Kingsbury SR, Hensor EMA, et al. Effect of bisphosphonate use in patients with symptomatic and radiographic knee osteoarthritis. Data from the osteoarthritis initiative. Ann Rheum Dis 2014;73:824-830.
66. Laslett LL, Quinn S, Burgess JR, et al. Moderate vitamin D deficiency is associated with changes in knee and hip pain in older adults: a 5-year longitudinal study. Ann Rheum Dis 2014;73:697-703.
67. McAlindon T, La Valley M, Schneider E, et al. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA 2013;309:155-162.
68. Reginster J-Y, Badurski J, Bellamy N, et al. Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Ann Rheum Dis 2013;72:179-186.
69. Pelletier J-P, Roubille C, Raynauld J-P, et al. Disease-modifying effect of strontium ranelate in a subset of patients from the Phase III knee osteoarthritis study SEKOIA using quantitative MRI: reduction in bone marrow lesions protects against cartilage loss. Ann Rheum Dis 2015;74:422-429.